Responsive Neurostimulator System (RNS) Long Term Treatment Investigation
This study os designed to assess the ongoing safety and to evaluate the long-term effectiveness of adjunctive RNS therapy in reducing siezures that are refractory to two or more antiepileptic medications.
Primary Sponsor: NeuroPace, Inc.
Prinicipal Investigator: Donald Shields
Are you interested in more information on this clinical trial?